Milestone Scientific Inc. (MLSS)

Market Cap	52.40M
Revenue (ttm)	8.88M
Net Income (ttm)	-4.62M
Shares Out	77.29M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	190,850
Open	0.611
Previous Close	0.620
Day's Range	0.600 - 0.690
52-Week Range	0.520 - 1.100
Beta	1.08
Analysts	Buy
Price Target	1.25 (+84.37%)
Earnings Date	Nov 14, 2024

About MLSS

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 3, 1995
• Employees: 17
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: MLSS
• Website: https://www.milestonescientific.com

Financial Performance

In 2023, Milestone Scientific's revenue was $9.83 million, an increase of 11.60% compared to the previous year's $8.81 million. Losses were -$6.93 million, -20.41% less than in 2022.

Analyst Forecast

According to one analyst, the rating for MLSS stock is "Buy" and the 12-month stock price forecast is $1.25.

Price Target

$1.25

(84.37% upside)

Analyst Consensus: Buy